Current Targeted Therapy Options in ROS1-Positive NSCLC: An overview of current FDA-approved ROS1-targeted therapies.

Subjects

Subjects :

NON-small-cell lung carcinoma
PROTO-oncogenes
GENE expression
CANCER cell proliferation

Details

Language :

English

Volume :

6

Issue :

7

Database :

Complementary Index

Journal :

Pharmacy Practice in Focus: Oncology

Publication Type :

Academic Journal

Accession number :

180259494